APEX Biologix Enters Into Know-How License Agreement with Mayo Clinic for Development of Regenerative Medicine Products
SALT LAKE CITY March 09, 2023, APEX Biologix, a leading regenerative medicine device company that sp...
Press Releases
APEX Biologix Appoints Jim Rogers as New Chief Executive Officer
APEX Biologix, a leader in the regenerative medicine industry, announced today the addition of a new...
APEX Biologix Announces New, Industry-Leading XCELL Protein Concentrator System
The new XCELL PC filter is more efficient, achieves greater concentrations, simplifies processing.
APEX Biologix Launches its Newly Reconfigured Bone Marrow System for Regenerative Medicine Procedures
XCELL BMC to Provide System Features Specifically Designed for Surgery Settings in Hospitals, Clinic...
APEX Biologix Chosen to Participate in the Mayo Clinic - Arizona State University MedTech Accelerator Program
APEX is one of eight companies selected internationally as part of distinguished group.
APEX Biologix Announces Sean Woodward as New Marketing Manager to our Salt Lake City Team
The addition to the APEX team will be an asset to help them continue their growth path.
APEX Biologix expands its XCELL product line to include a bone marrow concentration
Salt Lake City, Utah, May 23, 2019 – APEX Biologix is proud to introduce an exciting new bone marrow...
APEX Biologix: The release of its new Class II FDA approved XCELL PRP system.
Salt Lake City, Utah, April 8, 2019 – Today, APEX Biologix formally announced the launch of their ne...
Due to the overwhelming demand and popularity of the XCELL PRP system, APEX Biologix
Salt Lake City, Utah, September 25, 2018 – APEX Biologix would like to formally thank all their clie...
APEX Biologix announces their new XCELL PRP system
Salt Lake City, Utah, July 10, 2018 – APEX Biologix formally announced today the launch of their new...
APEX Biologix, LLC Partnership with Physicians Success RX, LLC
Salt Lake City, Utah, December 1, 2017 – Representatives from APEX Biologix, LLC are pleased to anno...
